Quantcast

Latest Diabetes Stories

2014-07-07 16:23:07

On and off the track, Reed shows that diabetes doesn't slow him down INDIANAPOLIS and ALEXANDRIA, Va., July 7, 2014 /PRNewswire/ -- News Highlights: -- #DiabetesChamp & Lilly #Diabetes ambassador @driverRyanReed finishes 4th at the Subway Firecracker 250 -- Lilly #Diabetes ambassador & @NASCAR driver @driverRyanReed takes 4th place at Subway Firecracker 250. Great job! #D2SD -- Lilly #Diabetes & @AmDiabetesAssn congratulate NASCAR driver...

2014-07-07 12:28:53

Agents That Can Elicit Greater Weight Loss Remain a Key Unmet Need for Both Physicians and Payers, According to Findings from Decision Resources Group BURLINGTON, Mass., July 7, 2014 /PRNewswire/ -- Decision Resources Group finds that Novo Nordisk's fixed-dose combination (FDC) therapy insulin degludec/liraglutide (Xultophy, formerly known as IDegLira) is set to become the clinical gold-standard among FDCs used to treat patients with type 2 diabetes. The competitive advantages that this...

2014-07-07 12:24:22

LONDON, July 7, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: MarketVIEW: diabetes vaccineshttp://www.reportbuyer.com/pharma_healthcare/therapeutic/marketview_diabetes_vaccines.html Diabetes is a metabolic disorder where the pancreas produces little or no insulin (Type I) OR cells do not respond appropriately to insulin that is produced (Type II). It is estimated that the global prevalence of diabetes is estimated at over 371 million people, a number...

2014-07-07 08:27:28

VISTA, Calif. and HARTFORD, Conn., July 7, 2014 /PRNewswire/ -- AutoGenomics, Inc, a leader in automated microarray technology for molecular diagnostics, and Genomas, a biomedical company enabling DNA-guided medicine for personal healthcare, announced today that they have signed an agreement to jointly develop genetic tests and DNA-guided diagnostic systems for optimal selection of statins and for improved delivery of statin therapy for the treatment of cardiovascular disease, obesity...

2014-07-06 23:02:02

Reverse Your Diabetes Today is a special program created by Matt Traverso specifically designed for all sufferers of diabetes to combat their ailments simply by following a more “organic” approach to their treatment. Vinamy.com recently published a review of the product for the website. Seattle, WA (PRWEB) July 06, 2014 Diabetes is so frighteningly common these days that most sufferers are those who belong in the lower-income brackets of society. Obviously, this has become such cause...

2014-07-04 23:01:32

Cheapesthealthinsurancecost.com announces a new blog post, “Can Seniors With Diabetes Buy Life Insurance?”. (PRWEB) July 04, 2014 Cheapesthealthinsurancecost.com has released a new blog post explaining how to purchase life insurance for seniors who have diabetes. Senior citizens can purchase life insurance even if they have diabetes. A life insurance policy can provide important financial relief for vulnerable family members. A funeral ceremony can amount to almost $10,000, a sum that...

early celiac sign
2014-07-04 03:30:55

NIH/National Institute of Diabetes and Digestive and Kidney Diseases NIH-funded study finds higher celiac risk in Sweden than US, elsewhere More than one quarter of children with two copies of a high-risk variant in a specific group of genes develop an early sign of celiac disease called celiac disease autoimmunity (CDA) by age 5. The findings are from The Environmental Determinants of Diabetes in Youth consortium, or TEDDY. The National Institutes of Health-funded study, published July...

2014-07-03 12:25:46

NEW YORK, July 3, 2014 /PRNewswire/ -- MannKind Corporation (NASDAQ: MNKD) is a biopharmaceutical company focused on the discovery and development of therapeutic products for diseases such as diabetes. The company's lead product - Afrezza inhalation powder - was recently approved by the FDA as a rapid-acting insulin therapy intended to improve glycemic control in adults with type 1 or type 2 diabetes. MannKind was founded by Al Mann for the purpose of developing inhaled insulin as an...

2014-07-03 11:56:28

The Lancet Insulin pumps are significantly more effective at controlling blood glucose (sugar) in people with type 2 diabetes who have failed to respond to the usual standard of care, multiple daily insulin injections, according to the largest international study to examine the safety and effectiveness of the pumps to treat type 2 diabetes, published in The Lancet. Type 2 diabetes is usually controlled by diet and medication, but most people with advanced disease also end up needing...

2014-07-03 11:14:23

Diabetologia A systematic review and meta-analysis of available data published in Diabetologia (the journal of the European Association for the Study of Diabetes) suggests that combined aerobic and resistance training, rather than either alone, is best for controlling both blood sugar and blood fat profiles among people with type 2 diabetes. However the authors stress that the strength of the results is weakened when studies with high risk of bias are removed, and thus more high quality...


Latest Diabetes Reference Libraries

Diabetes (journal)
2012-05-12 21:44:48

Diabetes is a peer-reviewed medical journal published since 1952 by the American Diabetes Association. Diabetes is a separate journal from the journal Diabetes Care, which is also published by the ADA. Diabetes covers research about the physiology and pathophysiology of diabetes mellitus, including any aspect of laboratory, animal or human research. Emphasis is on investigative reports focusing on areas such as the pathogenesis of diabetes and its complications, normal and pathologic...

Diabetes Care
2012-05-12 21:41:27

Diabetes Care is a peer-reviewed medical journal established in 1978 and published monthly by the American Diabetes Association. It covers research in the following five categories: clinical care/education/nutrition/psychosocial research; epidemiology/health services research; emerging treatments and technologies; pathophysiology/complications; and cardiovascular and metabolic risk. The journal also publishes clinically relevant review articles, letters to the editor, and commentaries....

0_0d961f30bdfa64859d9b869b063ddcd2
2010-12-03 18:12:26

Insulin, a hormone, is used to regulate carbohydrate and fat metabolism in the body. Insulin causes cells to take up glucose from the blood and store it as glycogen in the liver and muscle. This hormone stops the body from using fat as an energy source by inhibiting the release of glucagons. Without insulin the body fails to take glucose into the bodies cells and in turns uses fat as an energy source. It also has several other anabolic effects throughout the body. Diabetes mellitus results...

More Articles (3 articles) »
Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related